Condition

Ischemic Heart Failure

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18
Recruiting2
Common interventions25
Lead sponsors shown14
Advertisement

Clinical trials

18 shown
FAPl Imaging Assessment of Revascularization Outcome in Ischemic Heart FailureNCT07657650 · 2026-04-10
RECRUITING
CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection FractionNCT06258447 · 2024-08-01
RECRUITING
hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart DiseaseNCT07471698 · 2026-10-20
NOT_YET_RECRUITING
HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass SurgeryNCT07646210 · 2026-09-01
NOT_YET_RECRUITING
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)NCT07347197 · 2026-01-01
NOT_YET_RECRUITING
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart FailureNCT05566600 · 2022-10-09
UNKNOWN
Clinical Study of Lipoic Acid on Ischemic Heart FailureNCT03491969 · 2019-01-01
COMPLETED
A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)NCT02875639 · 2016-06-01
UNKNOWN
Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart FailureNCT03206593 · 2016-01-01
UNKNOWN
PARACHUTE China Approval TrialNCT02240940 · 2014-09-01
TERMINATED
LifeVest Wearable Cardioverter Defibrillator WEARIT-III RegistryNCT02700880 · 2014-06-01
COMPLETED
Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203NCT02115568 · 2014-01-01
UNKNOWN
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart FailureNCT01961726 · 2013-10-01
UNKNOWN
Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart FailureNCT01709279 · 2012-08-01
UNKNOWN
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.NCT01643590 · 2012-07-01
UNKNOWN
Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart FailureNCT01555320 · 2012-03-01
UNKNOWN
Resynchronization Surgery Combined Unified EfficacyNCT00846001 · 2007-09-01
COMPLETED
Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.NCT00102128 · 2002-11-01
TERMINATED

Common interventions

Trial status mix

UNKNOWN8
COMPLETED3
NOT_YET_RECRUITING3
RECRUITING2
TERMINATED2

Phase mix

PHASE27
NA4
PHASE14
EARLY_PHASE11
PHASE31
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.